2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow ALPN-101: new trials by email Literature Review of ALPN-101 trials Research Report on ALPN-101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus ALPN-101, Placebo - Systemic Lupus Erythematosus | Phase 2 | Completed | Alpine Immune Sciences Inc, A Subsidiary of Vertex | 76 | 2021-06-22 | 2025-08-15 |
| ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD ALPN-101 - Graft Vs Host Disease | Phase 1 | Terminated | Alpine Immune Sciences, Inc. | 1 | 2020-05-11 | 2023-08-28 |
| Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety ALPN-101, Placebo - Healthy Volunteers | Phase 1 | Completed | Alpine Immune Sciences, Inc. | 96 | 2019-01-29 | 2019-12-05 |
Autoimmune Diseases (1) · Graft vs Host Disease (1) · Immune System Diseases (1) · Lupus Erythematosus, Systemic (1)
Alpine Immune Sciences, Inc. (2) · Alpine Immune Sciences Inc, A Subsidiary of Vertex (1)
United States (2) · Australia (1) · France (1) · Hungary (1) · Poland (1) · Puerto Rico (1) · Spain (1) · Taiwan (1)
Jan Hillson, MD (1)